Pfizer shares are down nearly 9% in the past 3 months and severely lagging the broader market. Watch the video to find out if The Oxford Club’s Marc Lichtenfeld and Carter Worth of Sterne Agee think this stock is going to recover anytime soon.
Talking Numbers – CNBC | This Chart Spells Trouble for Pfizer
